Product Information

SERTRALINE 150 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $1.1436 per EA under NDC 69097043802. Its NADAC has been published 64 times since Sep 3, 2025.

FDA first approved this application on Jul 16, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SERTRALINE 150 MG CAPSULE

Sertraline Hydrochloride
$1.1436per EA

Strength

150 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097043802

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

SERTRALINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA218853

FDA Approved

7/16/2025

TE Code

AB

On Market Since

7/17/2025

Pharmacological Classes

Cytochrome P450 2D6 Inhibitors
Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for SERTRALINE 150 MG CAPSULE has been published 64 times since Sep 3, 2025, and over the history we have for it it has declined 77.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.1436 per EA
All-time high$5.1702 (Nov 12, 2025)
All-time low$1.1436 (Nov 18, 2026)
52-week high$5.1565
52-week low$1.1436
Median price$4.7220
Average price$3.6680
Largest weekly change-33.8% (Jul 22, 2026)
Weeks tracked64
Tracking sinceSep 3, 2025

Price History

1W

-0.2%

1M

-8.6%

3M

-17.3%

6M

-67.8%

1Y

-77.9%

3Y

N/A

5Y

N/A

All

-77.9%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of SERTRALINE 150 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for SERTRALINE 150 MG CAPSULE, manufactured by Cipla USA Inc., is $1.1436 per EA (NDC 69097043802), effective Nov 18, 2026.

How has the price of SERTRALINE 150 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for SERTRALINE 150 MG CAPSULE has declined 77.9%. It has been tracked across 64 weekly CMS publications since Sep 3, 2025.

What are the highest and lowest recorded NADAC prices for SERTRALINE 150 MG CAPSULE?

Since Sep 3, 2025, the NADAC for SERTRALINE 150 MG CAPSULE has ranged from a low of $1.1436 (Nov 18, 2026) to a high of $5.1702 (Nov 12, 2025), with a median of $4.7220 per EA.

Are there cheaper alternatives to SERTRALINE 150 MG CAPSULE?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SERTRALINE 150 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures SERTRALINE 150 MG CAPSULE?

SERTRALINE 150 MG CAPSULE (NDC 69097043802) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.